The Saer/S gene regulatory system induces a pro-inflammatory cytokine response during staphylococcus aureus infection

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Watkins, Robert L ^a   Pallister, Kyler B ^a   Voyich, Jovanka M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; STAPHYLOCOCCUS PROTEIN R; STAPHYLOCOCCUS PROTEIN S; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL PERITONITIS; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DELETION MUTANT; EX VIVO STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; HOST PATHOGEN INTERACTION; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAPHYLOCOCCAL SKIN INFECTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PATHOLOGY; PERITONITIS; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MICE; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79955936418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019939     Document Type: Article

References (54)

1. Lowy FD, (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, et al. (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355: 666-674.
3. Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, et al. (2005) Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 353: 1245-1251.
4. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, et al. (2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States; establishing a national database. J Clin Microbiol 41: 5113-5120.
5. Centers for Disease Control and Prevention (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282: 1123.
6. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 359: 753-759.
7. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1761.
8. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth, et al. (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352: 1445-1453.
9. Deleo FR, Chambers HF, (2009) Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest 119 (9): 2464-2474.
10. Boucher HW, Corey GR, (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 (Suppl5): S344-S349.
11. Matin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 though 2000. N Engl J Med 348: 1546-1554.
12. Lappin E, Ferguson AJ, (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9: 281-290.
13. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA, (2009) The sepsis seesaw: tilting toward imunosuppression. Nat Med 15: 496-497.
14. Rittirsch D, Flierl MA, Ward PA, (2008) Harmful molecular mechanisms of sepsis. Net Rev Immunol 8: 776-787.
15. Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T, (1995) Endongenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun 63: 1165-1172.
16. Sasaki S, Miura T, Nishikawa S, Yamada K, Hiasue M, et al. (1998) Protective role of nitric oxide in Staphylococcus aureus in mice. Infect Immun 66: 1017-1022.
17. Voyich JM, Sturdevant DE, Braughton KR, Whitney AR, Said-Salim B, et al. (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175: 3907-3919.
18. Voyich JM, Vuong C, DeWald M, Nygarrd TK, Griffith S, et al. (2009) The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis 199: 1698-1706.
19. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, et al. (2006) Neutrophils in development of multiple organ failure. Lancet 368: 157-169.
20. Chavakis T, Preissner KT, Herrman M, (2007) The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol 28: 408-418.
21. Alves-Filho JC, de Freitas A, Spiller F, Souto FO, Cunha FQ, (2008) The role of neutrophils in severe sepsis. Shock 30: 3-9.
22. Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ, (2004) Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 40: 1-9.
23. Bronner S, Monteil H, Prevost G, (2004) Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbial Rev 28: 183-200.
24. Novick RP, (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
25. Giraudo AT, Martinez GL, Calzolari A, Nagel R, (1994) Characterization of a Tn925-induced mutant of Staphylococcus aureus altered exoprotein production. J Basic Microbiol 34: 317-322.
26. Giraudo AT, Rampone H, Calzolari A, Nagel R, (1996) Phenotypic characterization and virulence of sae- agr- mutant of Staphylococcus aureus. Can J Microbiol 42: 120-123.
27. Harraghy N, Kormanec J, Wolz C, Homerova D, Goerke C, et al. (2005) Sae is essential for expression of the staphylococcal adhesins Eap and Emp. Microbiology 151: 1789-1800.
28. Kuroda H, Kuroda M, Chi L, Hiramatsu K, (2007) Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 268: 98-105.
29. Liang X, Yu C, Sun J, Liu H, Landwehr C, et al. (2006) Inactivation of a two-componet signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Saphylococcus aureus. Infect Immun 268: 98-105.
30. Novick RP, Jiang D, (2003) The staphylococcal SaeRS system coordinates environmental signals with agr quorum sensing. Microbiology 149: 2709-2717.
31. Rogash K, Ruhmling V, Pane-Farre J, Hoper D, Weinberg C, et al. (2006) Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J Bacteriol 188: 7742-58.
32. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS, (2006) Regulation of Staphylococcus aureus α-toxin gene (hla) expression by agr, sarA, and sae invitro and in experimental endocarditis. J Infect Dis 194: 1267-1275.
33. Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, et al. (2010) SaeR binds a consensus sequence within virulence gene promotors to advance USA300 pathogenesis. J Infect Dis 201: 241-254.
34. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, et al. (2006) Methicillin-resistant S. aureus infections among patients in the hospital. New Engl J Med 355: 666-674.
35. Sriskandan S, Altmann DM, (2008) The immunology of sepsis. Pathology 214: 211-223.
36. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
37. McLoughlin RM, Lee JC, Kasper DL, Tzianabos AO, (2008) IFN-γ regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol 181: 1323-1332.
38. Zhao YX, Nilsson IM, Tarkowski A, (1998) The dual role of interferon-γ in experimental Staphylococcus aureus septicaemia versus arthritis. Immunol 1: 80-85.
39. Sasaki S, Nishikawa S, Miura T, Mizuki M, Yamada K, et al. (2000) Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. Infect Immun 68: 2424-2430.
40. Rozalska B, Wadstrom T, (1993) Interferon-γ, interleukin-1 and tumour necrosis factor-α during experimental murine staphylococcal infection. FEMS Immunol Med Microbiol 7: 145-152.
41. Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DYM, (2010) Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39-49.
42. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 40: 885-891.
43. Pantrangi M, Singh VK, Wolz C, Shukla SK, (2010) Staphylococcal superantigen-like genes, ssl5 and ssl8, are positively regulated by Sae and negatively by Agr in the Newman strain. FEMS Microbiol Lett 308: 175-184.
44. McCormick JK, Warwood JM, Schlievert PM, (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104.
45. Dinges MM, Orwin PM, Schlievert PM, (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13: 16-34.
46. Bianchi ME, (2007) DAMPs, PAMPs, and alarmins: all we need to know about danger. J Leukocyte Biol 81: 1-5.
47. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, et al. (1997) Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun 65: 1550-1556.
48. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, (1994) Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Investig 94: 1815-1822.
49. Heyer G, Saba S, Adamo R, Rush W, Soong G, (2002) Stpahylococccus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun 70: 127-133.
50. Grundmeier M, Tuchscherr L, Bruck M, Viemann D, Roth J, (2010) Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J Infect Dis 201: 871-880.
51. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, et al. (2002) Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819-1827.
52. Fridkin SK, Hageman JC, Morrison, Sanza LT, Como-Sabetti K, et al. (2005) Methicillin-resistant staphylococcus aureus disease in three communities. N Engl J Med 352: 1436-1444.
53. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, et al. (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279: 593-598.
54. Kasakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, et al. (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352: 468-475.